Reduce Lantus to 60-80% of the usual dose (approximately 11-14 units) when NPO
For a patient on Lantus 18 units daily who will be NPO, give 60-80% of the usual long-acting insulin dose, which equals approximately 11-14 units. This recommendation comes directly from the most recent ADA perioperative guidelines 1.
Rationale and Clinical Approach
The 2018 ADA Standards specifically state: "Withhold any other oral hypoglycemic agents the morning of surgery or procedure and give half of NPH dose or 60–80% doses of a long-acting analog or pump basal insulin" 1. This applies to NPO situations including surgical procedures.
Why Not Full Dose?
- Hypoglycemia risk increases dramatically when basal insulin continues at full dose without nutritional intake
- The 2018 guideline notes that a 25% reduction in evening insulin dose before surgery achieved better perioperative glucose control with decreased hypoglycemia risk 1
- Without carbohydrate intake, the insulin-to-glucose ratio becomes dangerously imbalanced
Monitoring Requirements
While NPO, the patient requires:
- Blood glucose monitoring every 4-6 hours minimum 1
- Short-acting insulin for correctional coverage as needed 1
- Target glucose range of 80-180 mg/dL perioperatively (tighter targets increase hypoglycemia without improving outcomes) 1
Critical Pitfall to Avoid
Never completely withhold basal insulin in type 2 diabetes patients already on insulin therapy. Complete cessation risks hyperglycemia and metabolic decompensation. The basal insulin provides essential background coverage even without oral intake 2.
Type 1 vs Type 2 Distinction
If this were type 1 diabetes, continuing basal insulin is even more critical—these patients must receive basal insulin even when NPO to prevent diabetic ketoacidosis 2. However, the question specifies type 2 diabetes, where the 60-80% reduction is appropriate.
Practical Dosing
For 18 units baseline:
- 60% = 11 units
- 80% = 14 units
- Start with 14 units (more conservative) if the patient has good recent glycemic control
- Use 11 units if there's been recent hypoglycemia or the NPO period will be prolonged
The timing should remain consistent with the patient's usual administration schedule 3.